Summary: Researchers developed a novel peptide, KS-133, to target cognitive dysfunction in schizophrenia. By using a brain-targeting peptide, KS-487, they successfully transported KS-133 across the blood-brain barrier. Their nanoparticle-based drug…
Tag: psychopharmacology
MDMA Variants Show Promise for Safer Psychotherapy
Summary: Researchers developed three new MDMA variants (ODMA, TDMA, and SeDMA) that retain the therapeutic benefits while reducing side effects. These compounds affect mood-regulating brain structures similarly to MDMA but…
Antidepressants Impact Brain Development – Neuroscience News
Summary: Using antidepressants during pregnancy, specifically fluoxetine (found in Prozac and Sarafem), can significantly affect a child’s brain development, particularly in the prefrontal cortex, potentially increasing the risk of mental…
Psychoactive Ibogaine and Magnesium Show Promise for PTSD
Summary: Ibogaine, a plant-based psychoactive drug combined with magnesium, effectively reduces PTSD, anxiety, and depression in veterans with traumatic brain injuries (TBI). The study, involving 30 U.S. special forces veterans,…
Unraveling Psychedelics’ Potential in Mental Health
Summary: Research delves into the potential of psychedelics like psilocybin for treating psychiatric disorders. Studies show varying effects of psilocybin on fear learning in rats and mice, dependent on sex…
Psilocybin Microdosing Promising for Mental Health Disorders
Summary: Researchers delve into the therapeutic potential of psilocybin microdosing, exploring its influence on stress resilience and compulsive behaviors in rats. While high-dose psilocybin therapy has been scrutinized for psychiatric…
MDMA Makes People Feel More Connected During Conversations
Summary: Researchers shed light on MDMA’s potential to foster feelings of connection in controlled environments. Their study reveals that individuals on MDMA or methamphetamine felt more connected during conversations compared…
Mood Dips During Pill Pause
Summary: Research reveals that women’s mood can decline during the 7-day pill-free interval of contraceptive cycles. The study evaluated the mental health of long-term pill users and found heightened anxiety…
Treating Mom’s Postnatal Depression with SSRIs Also Boosts Child Behavior
Summary: A new study found that treating postnatal depression with selective serotonin reuptake inhibitors (SSRIs) benefits not just mothers but also their children. The study, which analyzed data from over…
